Even though JD.com (NASDAQ:JD) has lost CN¥6.9b market cap in last 7 days, shareholders are still up 79% over 3 years It hasn't been the best quarter for JD.com, Inc.(NASDAQ:JD) shareholders, since the share price has fallen 29% in that time. But don't let that distract from the very nice return generated over three years. In the last three years the share price is up, 79%: better than the market. In light of the stock dropping 8.0% in the past week, we want to investigate the longer term story, and see if fundamentals have been the driver of the company's positive three-year return. Because JD.com made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth, at least for now. Generally speaking, companies without profits are expec

Intel$Intel(INTC)$ has been given a $35.00 price objective by research analysts at Sanford C. Bernstein in a research note issued to investors on Tuesday, Borsen Zeitungreports. Sanford C. Bernstein’s price target would suggest a potential downside of 7.24% from the stock’s current price.INTC has been the topic of a number of other research reports. Tigress Financial reissued a “buy” rating and set a $72.00 price target on shares of Intel in a research report on Friday, June 3rd. Barclays set a $45.00 target price on Intel in a research report on Friday, April 29th. Citigroup decreased their price target on Intel from $50.00 to $45.00 and set a “neutral” rating for the company in a report on Monday, June 6th. Raymond James upgraded Intel fr

KEY POINTS Despite falling 75% from its high, Netflix stock is still up 4,600% over the last 15 years. Netflix has seen subscriber and revenue growth decelerate substantially in recent years. Netflix recently selected Microsoft to power its ad-supported streaming service. The streaming pioneer is partnering with Microsoft on its ad-supported service.In 2007, Netflix $Netflix(NFLX)$ upended the entertainment industry when it launched the first streaming service, challenging traditional paid television with a less costly and more convenient alternative. Early on (and somewhat ironically), many industry executives failed to see Netflix as a threat, including the CEO of the now-defunct video rental chain Blockbuster.Everyone knows wha

Evolution Petroleum $Evolution(EPM)$ and Occidental Petroleum $Occidental(OXY)$ are both oils/energy companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and profitability.63.3% of Evolution Petroleum shares are owned by institutional investors. Comparatively, 86.2% of Occidental Petroleum shares are owned by institutional investors. 8.8% of Evolution Petroleum shares are owned by company insiders. Comparatively, 0.3% of Occidental Petroleum shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and

KEY POINTS Apple has generated a monster return of 560% over the past decade. Like Apple, Block and Axon blend hardware with software and services. These businesses take a page out of Apple's playbook.Apple has the kind of brand authority most companies will never achieve, and it has used that competitive advantage to build a verysticky business. Specifically, by pairing first-party hardware with software and services, Apple benefits from recurring revenue and high switching costs. That has made it a cash-flow machine, and shareholders have seen a 560% return over the past decade as a result. $Apple(AAPL)$ Block and Axon Enterprise aren't quite the same as Apple, but both have earned brand recognition in their industries whil

The addressable market for NVAX stock has evaporated as vaccination efforts continue $Novavax(NVAX)$ The Food and Drug Administration (FDA) will meet in June to determine approval for Novavax’s(NVAX) Covid-19 vaccine. The early rollout of it in the European Union has been underwhelming. NVAX stock could be severely overvalued as a result.In 2019, Novavax(NASDAQ:NVAX) was off to a promising start. It was one of the companies that participated in the federal government’s Operation Warp Speed program along with Moderna(NASDAQ:MRNA). Its differentiating factor is that it used different technologies than its rivals. Many investors were hoping that it would end up being the third or fourth commercially available Covid-19 vaccine. Unfortunate